Back to Search
Start Over
Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states
- Source :
- Clinical Pharmacology and Therapeutics. 30:385-389
- Publication Year :
- 1981
- Publisher :
- Springer Science and Business Media LLC, 1981.
-
Abstract
- Diflunisal is long-acting salicylate derivative. We examined the effect of single concomitant doses of three antacids on diflunisal bioavailability under fasting or fed conditions (30 min after finishing a standard meal). With the use of an open, randomized, and balanced design, one 250-mg diflunisal tablet was given to each of 12 healthy men under six conditions: fasted, no antacid; fed, no antacid; fasted, 15 ml of aluminum hydroxide gel; fed, 15 ml of aluminum hydroxide gel; fasted, 10 ml magnesium hydroxide suspension; and fed, 15 ml of an aluminum hydroxide/magnesium hydroxide mixture. Diflunisal plasma 0- to 48-hr area uiven to each of 12 healthy men under six conditions: fasted, no antacid; fed, no antacid; fasted, 15 ml of aluminum hydroxide gel; fed, 15 ml of aluminum hydroxide gel; fasted, 10 ml magnesium hydroxide suspension; and fed, 15 ml of an aluminum hydroxide/magnesium hydroxide mixture. Diflunisal plasma 0- to 48-hr area uiven to each of 12 healthy men under six conditions: fasted, no antacid; fed, no antacid; fasted, 15 ml of aluminum hydroxide gel; fed, 15 ml of aluminum hydroxide gel; fasted, 10 ml magnesium hydroxide suspension; and fed, 15 ml of an aluminum hydroxide/magnesium hydroxide mixture. Diflunisal plasma 0- to 48-hr area under the time curve (AUC), peak plasma concentrations, and 0-to 96-hr urinary excretion were determined. Food (alone) decreased peak plasma concentrations by 16% (P less than 0.05) but did not affect AUC or urinary excretion. Under fasting conditions, aluminum hydroxide reduced AUC by 26% (P less than 0.01), peak plasma concentrations by 46% (P less than 0.01), and urinary excretion by 14% (P less than 0.05). Magenisuum hydroxide suspension (in the fasting state) increased the early plasma concentrations (by 130% at 0.5 hr and 64% at 1 hr, P less than 0.05) and increased AUC by 10% (P less than 0.05) but had no effect on urinary excretion. In the fed state neither aluminum hydroxide nor the aluminum hydroxide/magnesium hydroxide mixture had any detectable effect.
- Subjects :
- Adult
Male
Magnesium Hydroxide
Time Factors
medicine.medical_treatment
Increased AUC
Inorganic chemistry
Biological Availability
chemistry.chemical_element
Diflunisal
Aluminum Hydroxide
chemistry.chemical_compound
Suspensions
Antacid
medicine
Humans
Pharmacology (medical)
Pharmacology
Clinical Trials as Topic
Chromatography
Chemistry
Magnesium
Standard meal
Fasting
Salicylates
Bioavailability
Postprandial
Food
Hydroxide
Antacids
Gels
medicine.drug
Subjects
Details
- ISSN :
- 15326535 and 00099236
- Volume :
- 30
- Database :
- OpenAIRE
- Journal :
- Clinical Pharmacology and Therapeutics
- Accession number :
- edsair.doi.dedup.....01886c285eced87a0513f38bddeaeb59
- Full Text :
- https://doi.org/10.1038/clpt.1981.177